Proportion of opioid treatment programs offering on-site testing for HIV, STIs declines
Wednesday, January 1, 2014 - 10:00
in Health & Medicine
A survey of opioid treatment programs finds that the proportion offering on-site testing for human immunodeficiency virus (HIV) and sexually transmitted infections (STIs) declined substantially between 2000 and 2011, despite guidelines recommending routine opt-out HIV testing in all health care settings, according to a study.